AI Verdict
TMO has stronger fundamentals based on our AI analysis.
ABBV vs TMO Fundamental Comparison
| Metric | ABBV | TMO |
|---|---|---|
| Revenue | $61.2B | $44.6B |
| Net Income | $4.2B | $6.7B |
| Net Margin | 6.9% | 15.0% |
| ROE | N/A | 12.6% |
| ROA | 3.2% | 6.1% |
| Current Ratio | 0.67x | 1.89x |
| Debt/Equity | N/A | 0.73x |
| EPS | $2.36 | $17.74 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs TMO: Frequently Asked Questions
Is ABBV or TMO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), TMO has stronger fundamentals. ABBV is rated HOLD (70% confidence) while TMO is rated BUY (73% confidence). This is not investment advice.
How does ABBV compare to TMO fundamentally?
AbbVie Inc. has ROE of N/A vs THERMO FISHER SCIENTIFIC INC.'s 12.6%. Net margins are 6.9% vs 15.0% respectively.
Which stock pays higher dividends, ABBV or TMO?
ABBV has a dividend yield of N/A or no dividend while TMO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or TMO for long term?
For long-term investing, consider that ABBV has HOLD rating with 70% confidence, while TMO has BUY rating with 73% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs TMO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs TMO, the AI consensus favors TMO based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.